Skip to main content

Research Repository

Advanced Search

Clinical significance of Pseudomonas aeruginosa 2-alkyl-4-quinolone quorum-sensing signal molecules for long-term outcomes in adults with cystic fibrosis

Webb, Karmel; Fogarty, Andrew; Barrett, David A.; Nash, Edward F.; Whitehouse, Joanna L; Smyth, Alan R.; Stewart, Iain; Knox, Alan; Williams, Paul; Halliday, Nigel; Barr, Helen L.; Cámara, Miguel

Authors

KARMEL WEBB Karmel.Webb@nottingham.ac.uk
Clinical Research Fellow

ANDREW FOGARTY andrew.fogarty@nottingham.ac.uk
Clinical Associate Professor & Reader in Clinical Epidemiology

David A. Barrett

Edward F. Nash

Joanna L Whitehouse

Profile Image

ALAN SMYTH alan.smyth@nottingham.ac.uk
Professor of Child Health

Alan Knox

PAUL WILLIAMS paul.williams@nottingham.ac.uk
Professor of Molecular Microbiology

Nigel Halliday

Helen L. Barr



Abstract

Introduction : Pseudomonas aeruginosa is an important respiratory pathogen in cystic fibrosis (CF), which is associated with an accelerated decline in lung function, frequent pulmonary exacerbations and increased mortality. P. aeruginosa produces intercellular signalling molecules including 2-alkyl-4-quinolones (AQs), which regulate virulence factor production and biofilm formation in the CF airways. Studies have shown that AQs are detectable in the sputum and plasma of adults with CF and chronic pulmonary P. aeruginosa.
Aim: We tested the hypothesis that the presence of six AQs in plasma or sputum obtained from adults with CF was associated with long term adverse clinical outcomes.
Methodology: We analysed clinical data over an 8-year follow period for 90 people with CF who had previously provided samples for AQ analysis at clinical stability. The primary outcome was all cause mortality or lung transplantation. Secondary outcomes were rate of lung function decline and number of intravenous (IV) antibiotic days for pulmonary exacerbations.
Results: There was no statistical association between the presence of any of the six measured AQs and the primary outcomes or the secondary outcome of decline in lung function. One of the 6 AQs was associated with IV antibiotic usage. The presence of 2-nonyl-3-hydroxy-4(1H)-quinolone (C9-PQS) in sputum was associated with an increase in the number of IV antibiotic days in the follow up period (Mann-Whitney; p=0.011).
Conclusion: Further investigation to confirm the hypothesis that C9-PQS may be associated with increased antibiotic usage for pulmonary exacerbations is warranted as AQ-dependent signalling is a potential future target for anti-virulence therapies.

Citation

Webb, K., Fogarty, A., Barrett, D. A., Nash, E. F., Whitehouse, J. L., Smyth, A. R., …Cámara, M. (2019). Clinical significance of Pseudomonas aeruginosa 2-alkyl-4-quinolone quorum-sensing signal molecules for long-term outcomes in adults with cystic fibrosis. Journal of Medical Microbiology, 68(12), 1823-1828. https://doi.org/10.1099/jmm.0.001099

Journal Article Type Article
Acceptance Date Oct 4, 2019
Online Publication Date Oct 31, 2019
Publication Date Dec 1, 2019
Deposit Date Oct 4, 2019
Publicly Available Date Oct 31, 2019
Journal Journal of Medical Microbiology
Print ISSN 0022-2615
Electronic ISSN 1473-5644
Publisher Microbiology Society
Peer Reviewed Peer Reviewed
Volume 68
Issue 12
Pages 1823-1828
DOI https://doi.org/10.1099/jmm.0.001099
Keywords Microbiology (medical); Microbiology; General Medicine
Public URL https://nottingham-repository.worktribe.com/output/2748237
Publisher URL https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.001099

Files





You might also like



Downloadable Citations